Kimberly-Clark is buying Kenvue, the maker of Tylenol, after months of controversy around whether the medicine is linked to ...

Kenvue missed Wall Street estimates for third-quarter sales on Monday, while it also announced its acquisition by ...

Huggies’ maker Kimberly-Clark announced Monday it’s buying Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a consumer product conglomerate.

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

2025 hasn't been kind to Kenvue ( KVUE +15.03%) stock lately. Shares of the one-time Johnson & Johnson unit got hit hard after President Donald Trump said it was "not good" for women to take Tylenol ...

The news comes as Kenvue maker Tylenol has been embroiled in litigation surrounding the alleged relationship between Tylenol ...

One of biggest takeovers so far this year will create a global company with annual revenues of roughly $32 billion.

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...

Kimberly‑Clark said on Nov. 3, 2025 that it is planning to acquire Kenvue, the former Johnson & Johnson unit and maker of ...

Kimberly-Clark is buying the parent company of Tylenol, Kenvue, in a cash and stock deal worth about $48.7 billion. The deal ...

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two ...